Valuation
- Market cap
- 2,558,512,000
- Revenue TTM
- $2,122,840,000
- Net income TTM
- $22,920,000
- PE ratio
- 93.76
- Forward PE
- 74.30
- Profit margin
- 1.08%
- Debt to equity
- 0.00
Trading
- Volume
- 1,284,100
- Avg volume
- 1,225,106
- Day's range
- $19.96 – $20.33
- Shares out
- 127,734,000
- Stochastic %K
- 95%
- Beta
- 0.80
- Analysts
- Strong Sell
- Price target
- $31.67
Company profile
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that...
Show more
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. In addition, the company operates accountable care organization, which engages patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect across platform to better understand the holistic needs of each patient and connect with other providers to address individual medical needs. The company was founded in 2007 and is headquartered in Arlington, Virginia.
- Industry
- Health Information Services
- Sector
- Healthcare
- Phone
- 571 366 8850
- Website
- https://www.priviahealth.com
- Address
- 950 North Glebe Road, Suite 700, Arlington, United States
Latest news
No headlines yet.